Sagimet Biosciences Announces Publication of Results From Phase 2B Fascinate-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 Mash in the Lancet Gastroenterology & Hepatology
Sagimet生物科學公司宣佈，在《柳葉刀》《肝胃病學與肝病學雜誌》上公佈了Denifanstat在經活檢證實的F2/F3 Mash中的第20億次Fascinate-2臨床試驗結果
